Presentation Title
Complication with the Flu Vaccine, Injection Technique, Case Study
Format
Event
Start Date
12-2-2010 12:00 AM
Abstract
Case Study Background. A 40 year old female student received a FluLava (GlaxoSmithKline) trivalent inactivated influenza vaccine. Patient states within 2 hours of vaccination, she experienced left shoulder pain and within 24 hours severely compromised range of motion. Patient states that she felt the injection was right under the acromium of the shoulder, very high compared to other injections. She felt the injection in the joint. The injection was given by a Pharmacist as their first injection provided. Methods. Clinical presentation and follow-up treatments: – Patient states problems with ADLs � AROM flex 50°, abd 75°; PROM flex 90°, abd 120° � 3/5 MMT supraspinatus; 4/5 MMT IR & ER – Physical Therapy treatment – Steroid injection (RX) Reviewed risks:benefits & post care instructions � 5cc mixture 2:2:1 lidocaine:marcaine:kenalog (40mg) - Impression/Assessment: (L) shoulder pain; (L) shoulder adhesive capsulitis Conclusion. This presentation will cover the Vaccine Adverse Event Reporting System, Pharmacists’ ability to provide injections, and treatment regimen. Grants. None.
Complication with the Flu Vaccine, Injection Technique, Case Study
Case Study Background. A 40 year old female student received a FluLava (GlaxoSmithKline) trivalent inactivated influenza vaccine. Patient states within 2 hours of vaccination, she experienced left shoulder pain and within 24 hours severely compromised range of motion. Patient states that she felt the injection was right under the acromium of the shoulder, very high compared to other injections. She felt the injection in the joint. The injection was given by a Pharmacist as their first injection provided. Methods. Clinical presentation and follow-up treatments: – Patient states problems with ADLs � AROM flex 50°, abd 75°; PROM flex 90°, abd 120° � 3/5 MMT supraspinatus; 4/5 MMT IR & ER – Physical Therapy treatment – Steroid injection (RX) Reviewed risks:benefits & post care instructions � 5cc mixture 2:2:1 lidocaine:marcaine:kenalog (40mg) - Impression/Assessment: (L) shoulder pain; (L) shoulder adhesive capsulitis Conclusion. This presentation will cover the Vaccine Adverse Event Reporting System, Pharmacists’ ability to provide injections, and treatment regimen. Grants. None.